Activation of ERK1/2 Causes Pazopanib Resistance via Downregulation of DUSP6 in Synovial Sarcoma Cells.
about
Activation of ERK1/2 Causes Pazopanib Resistance via Downregulation of DUSP6 in Synovial Sarcoma Cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 March 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Activation of ERK1/2 Causes Pa ...... SP6 in Synovial Sarcoma Cells.
@en
Activation of ERK1/2 Causes Pa ...... SP6 in Synovial Sarcoma Cells.
@nl
type
label
Activation of ERK1/2 Causes Pa ...... SP6 in Synovial Sarcoma Cells.
@en
Activation of ERK1/2 Causes Pa ...... SP6 in Synovial Sarcoma Cells.
@nl
prefLabel
Activation of ERK1/2 Causes Pa ...... SP6 in Synovial Sarcoma Cells.
@en
Activation of ERK1/2 Causes Pa ...... SP6 in Synovial Sarcoma Cells.
@nl
P2093
P2860
P356
P1433
P1476
Activation of ERK1/2 Causes Pa ...... SP6 in Synovial Sarcoma Cells.
@en
P2093
Akira Nabeshima
Jun-Ichi Fukushi
Makoto Endo
Mihoko Hatano
Nobuhiko Yokoyama
Suguru Fukushima
Tomoya Matsunobu
Yoshihiro Matsumoto
Yukihide Iwamoto
P2860
P2888
P356
10.1038/SREP45332
P407
P50
P577
2017-03-28T00:00:00Z